News

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool has the potential to provide accessible and convenient care for people at risk of opioid overdose.

A new study has identified an antibody that can supercharge the immune system, helping to overcome a previously unknown mechanism by which cancer cells prevent phagocytosis.

Cells contain molecular machinery that targets and disposes of unwanted proteins. Scientists would like to hijack this process to control proteins involved in cancer and other diseases, using a type of molecule called a molecular glue degrader.

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant.

A genomic tug of war for a gene activator could explain why some cancers respond to decitabine and others don't respond or become resistant over time.

Researchers have discovered previously unknown changes in a specific type of liver cells, potentially opening avenues for a new treatment for liver fibrosis, a potentially life-threatening condition.

Researchers have shed new light on the cellular processes behind Parkinson's and illustrated how disease progression can be halted in a mouse model.

The tension-activated repair patch used in animal trials plugs holes in discs in the spine like car tire patches and could prevent further disease progression.

Researchers have identified the genetic changes that occur during pancreatic cancer metastasis and have found a drug to disrupt the process.

Nearly one in five school-aged children and preteens now take melatonin for sleep, and some parents routinely give the hormone to preschoolers, according to new research.